3.0.0 2503 2023-01-11T16:17:53Z 2023-01-11T16:17:53Z House H HR 2007-05-24 110 hsif00 Energy and Commerce Committee House Standing hsif14 Health Subcommittee Referred to 2007-05-24T19:53:11Z Referred to 2007-05-24T14:08:30Z 2007-05-24 hsif14 Health Subcommittee 1 House committee actions Referred to the Subcommittee on Health. Committee 2007-05-24 Referred to the House Committee on Energy and Commerce. IntroReferral H11100 2 House floor actions hsif00 Energy and Commerce Committee 2007-05-24 Introduced in House IntroReferral Intro-H 9 Library of Congress 2007-05-24 Introduced in House IntroReferral 1000 9 Library of Congress D000216 Rep. DeLauro, Rosa L. [D-CT-3] ROSA DELAURO D CT 3 N S001153 Rep. Solis, Hilda L. [D-CA-32] HILDA SOLIS D CA L. 32 2007-05-24 True F000030 Rep. Farr, Sam [D-CA-17] SAM FARR D CA 17 2007-05-24 True W000738 Rep. Woolsey, Lynn C. [D-CA-6] LYNN WOOLSEY D CA 6 2007-05-24 True G000551 Rep. Grijalva, Raúl M. [D-AZ-7] Raúl Grijalva D AZ M. 7 2007-05-24 True W000314 Rep. Wexler, Robert [D-FL-19] ROBERT WEXLER D FL 19 2007-05-24 True N000179 Rep. Napolitano, Grace F. [D-CA-38] GRACE NAPOLITANO D CA F. 38 2007-05-24 True S001145 Rep. Schakowsky, Janice D. [D-IL-9] JANICE SCHAKOWSKY D IL D. 9 2007-05-24 True S001174 Rep. Sutton, Betty [D-OH-13] Betty Sutton D OH 13 2007-05-24 True R000515 Rep. Rush, Bobby L. [D-IL-1] BOBBY RUSH D IL L. 1 2007-05-24 True B001230 Rep. Baldwin, Tammy [D-WI-2] Tammy Baldwin D WI 2 2007-06-11 False D000598 Rep. Davis, Susan A. [D-CA-53] SUSAN DAVIS D CA A. 53 2007-06-11 False K000180 Rep. Kilpatrick, Carolyn C. [D-MI-13] CAROLYN KILPATRICK D MI CHEEKS 13 2007-06-11 False C001036 Rep. Capps, Lois [D-CA-23] LOIS CAPPS D CA 23 2007-06-26 False H001032 Rep. Holt, Rush [D-NJ-12] RUSH HOLT D NJ D. 12 2007-09-04 False W000784 Rep. Wynn, Albert Russell [D-MD-4] ALBERT WYNN D MD R. 4 2007-09-07 False E000179 Rep. Engel, Eliot L. [D-NY-17] ELIOT ENGEL D NY L. 17 2007-09-18 False A000014 Rep. Abercrombie, Neil [D-HI-1] NEIL ABERCROMBIE D HI 1 2007-09-24 False B000657 Rep. Boucher, Rick [D-VA-9] RICK BOUCHER D VA 9 2007-09-24 False R000462 Rep. Rothman, Steven R. [D-NJ-9] STEVEN ROTHMAN D NJ R. 9 2007-09-24 False S001169 Rep. Sestak, Joe [D-PA-7] Joe Sestak D PA 7 2007-10-17 False D000197 Rep. DeGette, Diana [D-CO-1] DIANA DEGETTE D CO 1 2008-02-13 False Health Administrative procedure Child health Commerce Communication in medicine Communication in science Conferences Consumer education Contraceptives Department of Health and Human Services Environmental Protection Executive reorganization Families Food and Drug Administration (FDA) Government Operations and Politics Ionizing radiation Labeling Law Medical research Medical supplies Platinum Product safety Prosthesis Science, Technology, Communications Women Women's health Health 00 2007-05-24 Introduced in House 2007-08-22T20:28:03Z FDA Scientific Fairness for Women Act - Amends the Federal Food, Drug, and Cosmetic Act to establish the Office of Women's Health within the Office of the Commissioner of the Food and Drug Administration (FDA).

Deems a breast implant to be a class III medical device. Requires premarket approval of breast implants irrespective of whether the implant has been cleared for commercial distribution in interstate commerce before the date of enactment of this Act.

Prohibits the Secretary of Health and Human Services from finding that a reasonable assurance of safety has been shown for an application for premarket approval for a a breast implant unless the applicant involved has demonstrated its safety for the life of the implant. Deems an already approved breast implant to be unsafe under the conditions of use prescribed, recommended, or suggested in the labeling.

Requires the Secretary to: (1) issue appropriate, voluntary guidance for clinical care, removal, and replacement for breast implants; (2) require such guidance to be clearly expressed in the labeling and all marketing materials; and (3) require dissemination of such guidance to patients who have already received the implant.

Requires the Breast Implant Advisory Panel of the General and Plastic Surgery Advisory Committee to review the results and quality of the research on saline breast implants and silicone gel implants.

Requires the Secretary to study the ionization and levels of platinum in silicone breast implants.

Requires the Secretary, acting through the Commissioner of Food and Drugs, to convene a scientific workshop to review and evaluate current scientific data on the use of emergency contraception by females of childbearing potential under the age of 18.

]]> FDA Scientific Fairness for Women Act Display Title FDA Scientific Fairness for Women Act Official Title as Introduced To amend the Federal Food, Drug, and Cosmetic Act with respect to the Office of Women's Health and the regulation of breast implants, and to provide for a scientific workshop on the use of emergency contraception by women under age 18. Introduced in House IH Short Titles as Introduced FDA Scientific Fairness for Women Act Introduced in House 2007-05-24T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-110hr2503ih/xml/BILLS-110hr2503ih.xml 2007-05-24 Referred to the Subcommittee on Health. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.